You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 5,543,152


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,543,152
Title: Sphingosomes for enhanced drug delivery
Abstract:Liposomal formulations having extended circulation time in vivo and increased drug retention are comprised of sphingomyelin and cholesterol and have an acidic intraliposomal pH. The formulations have enhanced stability and thus are used in methods which provide improved drug delivery and more effective treatment. The delivery of lipophilic drugs such as the vinca alkaloids, and particularly vincristine and vinblastine, to tumors is significantly improved.
Inventor(s): Webb; Murray S. (Vancouver, CA), Bally; Marcel B. (Bowen Island, CA), Mayer; Lawrence D. (North Vancouver, CA)
Assignee: Inex Pharmaceuticals Corporation (Vancouver, CA)
Application Number:08/263,603
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Compound; Process; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,543,152: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 5,543,152, exploring its claims, scope, and the broader patent landscape it inhabits.

Background of the Patent

United States Patent 5,543,152, titled "Liposomal Formulations of Antineoplastic Agents," was granted to address the delivery of antineoplastic agents, such as camptothecin, in a more effective and targeted manner. This patent is part of a larger body of work focused on drug delivery systems, particularly those using liposomal formulations.

Understanding Patent Claims

Types of Claims

Patent claims are the legal definitions that specify the boundaries of the invention’s protection. There are two primary types of claims: independent and dependent claims. Independent claims stand alone, describing the invention in broad terms, while dependent claims refer back to an independent claim, adding further details or limitations[3].

Claims in US 5,543,152

The patent includes a series of claims that define the liposomal formulations and their methods of use. Here are some key aspects:

  • Independent Claims: These claims describe the broad scope of the invention, including the composition of the liposomal formulations and the antineoplastic agents they contain.
  • Dependent Claims: These claims add specific details to the independent claims, such as the types of lipids used in the formulation, the size of the liposomes, and the methods of administering the formulations.

Scope of the Invention

The scope of the invention is defined by the claims and includes:

  • Liposomal Formulations: The patent covers liposomal formulations comprising antineoplastic agents, which are designed to improve the delivery and efficacy of these agents.
  • Antineoplastic Agents: Specific agents like camptothecin are mentioned, highlighting the patent’s focus on cancer treatment.
  • Methods of Use: The patent also includes claims related to the methods of using these formulations, such as administration routes and dosages[5].

Patent Landscape

Prior Art and Related Patents

To understand the patent landscape, it is essential to look at prior art and related patents. The USPTO’s Patent Public Search tool and other international databases can be used to find related patents and applications. For example, patents like US 5,471,516 and US 5,814,335 also discuss liposomal formulations, indicating a rich body of prior art in this field[4].

Global Dossier and International Patent Offices

The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding how the patent is treated globally and any variations in claims or scope across different jurisdictions[1].

Common Citation Document (CCD)

The Common Citation Document (CCD) consolidates prior art cited by all participating offices for the family members of a patent application. This tool can help in identifying any overlapping or conflicting claims in the global patent landscape[1].

Strategic Claim Management

Effective patent claim management is crucial for maintaining the strength and enforceability of the patent. Here are some strategies relevant to US 5,543,152:

Crafting and Refining Claims

Claims should be crafted to ensure comprehensive protection and enforceability. This involves defining the invention’s scope thoughtfully, balancing broad protection with the need to avoid overlap with prior art[3].

Maximizing Claim Quotas

The USPTO allows a certain number of claims without additional fees. Strategic claim management involves utilizing this allowance to its fullest potential, ensuring the patent covers as many aspects of the invention as possible without exceeding cost thresholds[3].

Anticipating Examiner Rejections

Developing claims with an understanding of common grounds for rejection by the USPTO, such as non-obviousness and novelty issues, can streamline the prosecution process. Tailoring claims to preemptively address these concerns is essential[3].

Post-Grant Claim Adjustments

After the patent is granted, it is important to monitor and adjust claims as necessary. This includes:

Adapting to Change

Technologies evolve, and markets shift, so maintaining the relevance and enforceability of patent claims is essential. This may involve amending claims to reflect new developments or to strengthen the patent’s position[3].

Engaging in Strategic Prosecution

Engaging in strategic prosecution involves responding effectively to examiner feedback and leveraging examiner interviews to enhance the value and effectiveness of the patent[3].

Key Takeaways

  • Understand the Claims: Independent and dependent claims define the scope of the invention.
  • Scope of the Invention: Includes liposomal formulations, antineoplastic agents, and methods of use.
  • Patent Landscape: Consider prior art, related patents, and global dossier to understand the broader landscape.
  • Strategic Claim Management: Craft, refine, and manage claims to maximize protection and enforceability.
  • Post-Grant Adjustments: Monitor and adjust claims as technologies and markets evolve.

FAQs

What are the main types of claims in a patent?

The main types of claims are independent claims, which describe the invention broadly, and dependent claims, which add specific details to the independent claims[3].

How can I search for related patents?

You can use the USPTO’s Patent Public Search tool, Global Dossier, and other international patent databases to find related patents and applications[1].

Why is it important to manage patent claims strategically?

Strategic claim management helps in ensuring comprehensive protection, maximizing the use of claim quotas, and streamlining the prosecution process, ultimately enhancing the value and effectiveness of the patent[3].

What is the Common Citation Document (CCD)?

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, enabling users to visualize search results from several offices on a single page[1].

How do I adapt my patent claims to technological changes?

Monitor technological developments and market shifts, and be prepared to amend claims to reflect new information and strengthen the patent’s position[3].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,543,152

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,543,152

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 248586 ⤷  Subscribe
Australia 2709495 ⤷  Subscribe
Canada 2193502 ⤷  Subscribe
Germany 69531701 ⤷  Subscribe
European Patent Office 0804159 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.